The9 Limited
NASDAQ:NCTYElectronic Gaming & Multimedia
+$0.24 today
- Market cap
- $51.16M
- Beta
- 2.13
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$26.43
Volume 0.02M
Average 0.07M
NCTY EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
The9 LimitedNASDAQ: NCTY
EBITDA · Q4 FY2025 · quarter ended Dec 2025
EBITDA remains negative
Q4 FY2025 EBITDA was -CN¥25.07M, compared with -CN¥48.03M a year earlier.
Context
- EBITDA amounted to 342.8% of revenue in FY2025, up 254.1 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
CNY · from the income statement
- Latest · FY2025
- (369.85M) CNY
- Year-over-year change
- -268.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (369.85M) | -268.2% |
| FY2024 | 2024-12-31 | (100.44M) | +34.2% |
| FY2023 | 2023-12-31 | (152.74M) | +58.7% |
| FY2022 | 2022-12-31 | (369.62M) | -68.8% |
| FY2021 | 2021-12-31 | (219M) | — |
EBITDA vs competitors
How NCTY compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -268.2% is the lowest of 3, against a peer median of +28.7%.
- EBITDA amounts to 342.8% of revenue for NCTY, versus a peer median of 37.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $292K USD | +146.2% | — | 0.6% | |
| FY2025 | -HK$25.03M HKD | -88.7% | — | 74.0% | |
| FY2025 | -CN¥369.85M CNY | -268.2% | — | 342.8% | |
| Peer median (excluding NCTY) | — | +28.7% | — | 37.3% | |
Competitors are the stored peer set for NCTY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 134.12M | 104.93M | 174.02M | 113.3M | 107.9M |
| Cost of Revenue | 86.89M | 152.31M | 213.15M | 114.92M | 106.09M |
| Gross Profit | 47.22M | (47.38M) | (39.13M) | (1.63M) | 1.81M |
| Gross Margin | 35.2% | -45.2% | -22.5% | -1.4% | 1.7% |
| Research & Development | 1.89M | 2.43M | 1.97M | 868.13K | 9.8M |
| Selling, General & Admin | 311.11M | 363.43M | 198.49M | 160.32M | 239.77M |
| Operating Expenses | 313M | 614.15M | 200.46M | 161.19M | 249.57M |
| Depreciation & Amortization | 46.79M | 92.99M | 86.85M | 62.37M | 15.12M |
| EBITDA | (219M) | (369.62M) | (152.74M) | (100.44M) | (369.85M) |
| EBITDA Margin | -163.3% | -352.3% | -87.8% | -88.7% | -342.8% |
| Operating Income | (265.78M) | (661.53M) | (239.59M) | (162.81M) | (247.76M) |
| Operating Margin | -198.2% | -630.5% | -137.7% | -143.7% | -229.6% |
| Interest Income | 0 | 0 | 0 | 0 | 449K |
| Interest Expense | 119.17M | 23.34M | 31.38M | 34.22M | 23.26M |
| Other Income / Expenses | (145.65M) | (31.87M) | 95.33M | 88.13M | (161.05M) |
| Income Before Tax | (411.43M) | (693.41M) | (144.26M) | (74.69M) | (408.81M) |
| Pre-Tax Margin | -306.8% | -660.8% | -82.9% | -65.9% | -378.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 110K |
| Net Income | (405.91M) | (974.86M) | (138.79M) | (74.46M) | (402.45M) |
| Net Margin | -302.7% | -929.1% | -79.8% | -65.7% | -373.0% |
| EPS (Basic) | (234.00) | (288.00) | 6.00 | (15.69) | (51.00) |
| EPS (Diluted) | (234.00) | (288.00) | 6.00 | (15.69) | (51.00) |
| Weighted Avg Shares | 1.75M | 3.4M | 4.93M | 4.68M | 7.58M |
| Weighted Avg Shares (Diluted) | 1.65M | 2.4M | 4.93M | 4.68M | 7.58M |
The9 Limited
NASDAQ:NCTY
Intrinsic Alpha fair value
Locked
Current Price
$3.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.